Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisk denote omissions. COLLABORATION AND LICENSE AGREEMENT by and between AGIOS INTERNATIONAL SARL and CELGENE INTERNATIONAL II SARL Re:...Collaboration and License Agreement • August 7th, 2015 • Agios Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis Collaboration and License Agreement (this “Agreement”) is entered into as of April 27, 2015 (the “Effective Date”), by and between Agios International Sarl, a limited liability company organized and existing under the laws of Switzerland (“Agios”), and Celgene International II Sarl, a limited liability company organized and existing under the laws of Switzerland and having its principal office in the Canton of Neuchatel, Switzerland (“Celgene”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT by and between AGIOS PHARMACEUTICALS, INC. and CELGENE CORPORATION Re: AGI-23088...Collaboration and License Agreement • August 7th, 2015 • Agios Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis Collaboration and License Agreement (this “Agreement”) is entered into as of April 27, 2015 (the “Effective Date”), by and between Agios Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 38 Sidney St., 2nd Floor, Cambridge, MA 02139-4169 (“Agios”), and Celgene Corporation, a corporation organized and existing under the laws of the State of Delaware and having its principal office at 86 Morris Avenue, Summit, NJ 07901 (“Celgene”).